medpagetoday.com -- Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.
medpagetoday.com -- Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.